SCHEMBL24754129

SCHEMBL24754129

CCOC(=O)CC1CCN(CCCl)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
HIF1A Q16665 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
GMNN O75496 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
KMT2A Q03164 1/20 0.39
OPRM1 P35372 3/20 0.37
POLB P06746 2/20 0.36
PARP14 Q460N5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12442952 0.87 EPHX1 (0.41) POLBPARP14HTR4SMN1; SMN2L3MBTL1
SCHEMBL7332383 0.84 HTR4 (0.43) HTR4DRD2DRD4
SCHEMBL14104114 0.83 HSD11B1 (0.40) POLBPARP14KDM4EHTR4SMN1; SMN2
SCHEMBL12788543 0.82 CACNA1I (0.43) ALDH1A1MEN1LMNAKMT2APOLB
SCHEMBL5157288 0.82 CARM1 (0.51) PARP14SIGMAR1
SCHEMBL2607204 0.82 NCF1 (0.41) ALDH1A1LMNAMAPTKMT2APOLB
SCHEMBL13713538 0.80 POLB (0.36) LMNAPOLBPARP14HTR4USP14
SCHEMBL25713253 0.79 KDM4E (0.40) PKMALDH1A1LMNAPOLBPARP14
SCHEMBL18595476 0.78 POLB (0.40) ALDH1A1LMNAMAPTTHRBKMT2A
SCHEMBL12156690 0.78 PIK3CD (0.41) CYP2D6ALDH1A1MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022262782-A1 GLUTARIMIDE-SUBSTITUTED ISOXAZOLE FUSED RING COMPOUND, AND APPLICATION THEREOF 南京明德新药研发有限公司 2022-12-22 WO disclosed